ArticleJapanese journal of clinical oncology2021

The safety, tolerability and pharmacokinetics of niraparib in Japanese patients with solid tumours: results of a phase I dose-escalation study.

Kan Yonemori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.